20 articles
HIIT training studied in 52 men with prostate cancer on active surveillance to evaluate exercise benefits during watchful waiting.
First study tests whether supervised exercise training is safe and beneficial for bladder cancer patients during treatment.
Dr. Kerry Courneya reveals how structured exercise becomes therapeutic intervention that enhances treatment tolerance and survival.
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
A landmark ACSM consensus statement delivers the first evidence-based exercise guidelines for children and adolescents during and after cancer treatment.
A completed pilot trial tested physical therapy and progressive muscle relaxation to preserve function and mood in older adults with advanced lung cancer.
A completed trial examines how structured exercise reshapes body composition and sustains physical activity habits in breast cancer patients post-diagnosis.
A completed Phase 2 trial explores whether low-dose continuous chemotherapy can boost immunotherapy efficacy in advanced lung cancer.
Redirecting glucose metabolism during T cell expansion dramatically improves cancer immunotherapy effectiveness.
New research shows how activating PKM2 enzyme enhances CD8 T cell function and improves anti-PD1 cancer therapy effectiveness.
Novel treatment triggers ferroptosis in cancer cells while activating immune responses that further enhance cancer cell death.
Ketogenic diet metabolite enhances CAR T cell metabolism and tumor control in multiple cancer models
A new Science paper reveals that mitochondrial fitness in dendritic cells controls antitumor immunity — and can be targeted to boost immunotherapy.
New fusion model combines hypoxia and immune markers to predict hepatocellular carcinoma treatment success non-invasively.
Metabolite supplement protects heart from chemo toxicity and enhances tumor suppression in breakthrough dual-action study.
Peter Attia explains the science behind fasting as a tool to enhance chemotherapy efficacy while protecting healthy cells.
New review reveals how targeting mitochondria in cancer cells could overcome immunotherapy resistance and enhance anti-tumor responses.
A comprehensive review reveals how iron-driven cell death can be exploited to treat ATC, one of the most lethal human cancers.
A pilot trial tested a comprehensive physical, mental, and spiritual intervention for cancer survivors, tracking outcomes at 6 months post-program.
Novel nanoplatform delivers copper and iron ions to trigger both ferroptosis and cuproptosis in cancer cells.
